Iriska Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in District Hapur, Uttar Pradesh, India, established in 2018.
2018 District Hapur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Iriska Pharmaceuticals Private Limited

Iriska Pharmaceuticals Private Limited, a active private limited company, was established on 16 April 2018 in District Hapur, Uttar Pradesh, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U74999UP2018PTC103206. Registered under ROC Roc Uttar Pradesh Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rahul Yadav (Director), Priyanka Sharma (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 4, First Floor, City Plaza Gandhi Bazar, Pilkhuwa, District Hapur, Uttar Pradesh, 245304.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UP2018PTC103206

  • Registration Number

    103206

  • Incorporation Date

    16 April 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttar Pradesh Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 286.79%
  • Profit Growth **** 862.02%
  • Ebitda **** 130.36%
  • Net Worth 10.84%
  • Total Assets **** 79.34%
Company report

Iriska Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Iriska Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Iriska Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Yadav Director 16 Apr 2018 Current
Priyanka Sharma Director 16 Apr 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iriska Pharmaceuticals.

Iriska Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 286.79% increase. The company also saw a substantial improvement in profitability, with a 862.02% increase in profit. The company's net worth Soared by an impressive increase of 10.84%.

Iriska Pharmaceuticals revenue growth over time
Iriska Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 286.79%
*******
*******
*******
*******
Revenue from Operations
*******
 286.79%
*******
*******
*******
*******
Total Assets
*******
 79.34%
*******
*******
*******
*******
Profit or Loss
*******
 862.02%
*******
*******
*******
*******
Net Worth
*******
 10.84%
*******
*******
*******
*******
EBITDA
*******
 130.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iriska Pharmaceuticals?

Unlock access to Iriska Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Iriska Pharmaceuticals?

Unlock and access historical data on people associated with Iriska Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iriska Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iriska Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iriska Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Iriska Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Iriska Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii. was documented.

  • Director Appointment

    Progress on Rahul Yadav was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 8 years 1 month . was documented.

  • Director Appointment

    Progress on Priyanka Sharma was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 8 years 1 month . was documented.

  • Company Incorporation

    The activity Iriska Pharmaceuticals Private Limited was registered on 16 Apr 2018 with Roc Uttar Pradesh Ii & aged 8 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Iriska Pharmaceuticals Private Limited?

The CIN of Iriska Pharmaceuticals Private Limited is U74999UP2018PTC103206.

Where is Iriska Pharmaceuticals Private Limited headquartered?

Iriska Pharmaceuticals Private Limited is headquartered at Shop No. 4, First Floor, City Plaza Gandhi Bazar, Pilkhuwa, District Hapur, Uttar Pradesh, 245304.

When was Iriska Pharmaceuticals Private Limited incorporated?

Iriska Pharmaceuticals Private Limited was incorporated on 16 April 2018.

Who are the current directors of Iriska Pharmaceuticals Private Limited?

The current directors of Iriska Pharmaceuticals Private Limited are

What is the primary industry of Iriska Pharmaceuticals Private Limited?

The primary industry of Iriska Pharmaceuticals Private Limited is Healthcare.

Is Iriska Pharmaceuticals Private Limited a listed company?

Iriska Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Iriska Pharmaceuticals Private Limited?

The authorized capital of Iriska Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available